Bausch Health Companies Inc.

BHC ·Healthcare, Drug Manufacturers - General, Quebec, Canada
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009 FY2008
Operating Activities
Net Income $406.6M $199.9M
Depreciation & Amortization $149.3M —
Depreciation $18.8M —
Amortization $113.9M $51.4M
Stock-Based Compensation $5.6M $7.9M
Net Cash from Operating Activities $360.9M $204.3M
Investing Activities
Capital Expenditures $7.4M $22.0M
Business Acquisitions — —
Net Cash from Investing Activities $-742.8M $-107.8M
Financing Activities
Dividends Paid $147.1M $180.3M
Stock Repurchases — $29.8M
Net Cash from Financing Activities $177.0M $-210.3M
Net Change in Cash $-203.1M $-116.1M
Free Cash Flow $353.5M $182.3M
← Newer Page 3 of 3 Older →